Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-22-014698

CEO bought 75,000 shares at $0.30 ($22,230)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Woods Lori A CEO 2022-06-07 Purchase +75,000 $0.30 $22,230 1,047,038 I
Open-market purchases · 75,000 sh · avg $0.30 · $22,230
Loading xslF345X03/rdgdoc.xml…